Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment - PharmaTimes Orphan drug designation offers development incentives and potential market exclusivity

#Zydus #neurodegenerativedisease #neuroscience #neurology #neurodegeneration #USFDA #FDA #OrphanDrugDesignation #ODD #Usnoflast #NLRP3inhibitor #ALS #amyotrophiclateralsclerosis #ALStreatment #FDAapproval #ZydusLifesciences #Parkinsonsdisease #MultipleSclerosis
pharmatimes.com/news/zydus-a...